The hyperactive syndrome: Metanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity

Behavioural Brain Research

Volumn 194, Issue 1, 2008, Pages 1-14

  Viggiano, Davide ^a  

^a UNIVERSITY OF MOLISE   (Italy)

Author keywords

Critical period; Exploration; Genes; Hyperactivity; Knock out; Lesions; Mice

Indexed keywords

ACETYLCHOLINE; CALCIUM CHANNEL; CATECHOLAMINE; ENDOCANNABINOID; GROWTH FACTOR; ION CHANNEL; NITRIC OXIDE; NORADRENALIN; OPIATE; OREXIN; POTASSIUM CHANNEL; SEROTONIN; SEROTONIN RECEPTOR; SOMATOSTATIN; TRANSCRIPTION FACTOR;

ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; BEHAVIOR CONTROL; BEHAVIOR DISORDER; BRAIN DAMAGE; BRAIN REGION; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; GENE MUTATION; HORMONAL REGULATION; HYPERACTIVE SYNDROME; INNER EAR DISEASE; LOCOMOTION; METABOLIC REGULATION; METABOLIC STRESS; MOTOR PERFORMANCE; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; REVIEW; RODENT; SECOND MESSENGER;

ANIMALS; BRAIN INJURIES; DATABASES, FACTUAL; HUMANS; HYPERKINESIS; META-ANALYSIS AS TOPIC; MICE; MOTOR ACTIVITY;

EID: 50049089999     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.06.033     Document Type: Review

References (257)

1. [Anonymous]. Genesis; 2008.
2. Abramov U., Raud S., Koks S., Innos J., Kurrikoff K., Matsui T., et al. Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice. Behav Brain Res 155 (2004) 1-11
3. Acevedo S.F., Ohtsu H., Benice T.S., Rizk-Jackson A., and Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res 1071 (2006) 113-123
4. Alexander R.C., Wright R., and Freed W. Quantitative trait loci contributing to phencyclidine-induced and amphetamine-induced locomotor behavior in inbred mice. Neuropsychopharmacology 15 (1996) 484-490
5. Allen J.P., Hathway G.J., Clarke N.J., Jowett M.I., Topps S., Kendrick K.M., et al. Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur J Neurosci 17 (2003) 1881-1895
6. Alttoa A., Koiv K., Eller M., Uustare A., Rinken A., and Harro J. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity. Neuroscience 132 (2005) 979-990
7. Anthony A., Adams P.M., and Stein S.A. The effects of congenital hypothyroidism using the hyt/hyt mouse on locomotor activity and learned behavior. Horm Behav 27 (1993) 418-433
8. Archer T., Fredriksson A., Sundstrom E., Luthman J., Lewander T., Soderberg U., et al. Prenatal methylazoxymethanol treatment potentiates d-amphetamine- and methylphenidate-induced motor activity in male and female rats. Pharmacol Toxicol 63 (1988) 233-239
9. Asherson P., Chen W., Craddock B., and Taylor E. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 190 (2007) 4-5
10. Ashkenazi R., Finberg J.P., and Youdim M.B. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker. Br J Pharmacol 79 (1983) 765-770
11. Asmussen G., Schmalbruch I., Soukup T., and Pette D. Contractile properties, fiber types, and myosin isoforms in fast and slow muscles of hyperactive Japanese waltzing mice. Exp Neurol 184 (2003) 758-766
12. Avale M.E., Falzone T.L., Gelman D.M., Low M.J., Grandy D.K., and Rubinstein M. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry 9 (2004) 718-726
13. Backman C., You Z.B., Perlmann T., and Hoffer B.J. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behav Brain Res 143 (2003) 95-100
14. Balogh S.A., McDowell C.S., and Denenberg V.H. Behavioral characterization of mice lacking the ubiquitin ligase UBR1 of the N-end rule pathway. Genes Brain Behav 1 (2002) 223-229
15. Barbelivien A., Ruotsalainen S., and Sirvio J. Metabolic alterations in the prefrontal and cingulate cortices are related to behavioral deficits in a rodent model of attention-deficit hyperactivity disorder. Cereb Cortex 11 (2001) 1056-1063
16. Barrera C.M., Hunter R.E., and Dunlap W.P. Hyperuricemia and locomotor activity in developing rats. Pharmacol Biochem Behav 33 (1989) 367-369
17. Bass C.E., and Martin B.R. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 60 (2000) 113-119
18. Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J Biol Chem 281 (2006) 32072-32080
19. Begou M., Brun P., Bertrand J.B., Job D., Schweitzer A., D'Amato T., et al. Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse 61 (2007) 689-697
20. Beninger R.J., Jhamandas A., Aujla H., Xue L., Dagnone R.V., Boegman R.J., et al. Neonatal exposure to the glutamate receptor antagonist MK-801: effects on locomotor activity and pre-pulse inhibition before and after sexual maturity in rats. Neurotox Res 4 (2002) 477-488
21. Blednov Y.A., Stoffel M., Cooper R., Wallace D., Mane N., and Harris R.A. Hyperactivity and dopamine D1 receptor activation in mice lacking girk2 channels. Psychopharmacology (Berl) 159 (2002) 370-378
22. Boldry R.C., Willins D.L., Wallace L.J., and Uretsky N.J. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Brain Res 559 (1991) 100-108
23. Bond T.L., Drage M., and Heinrichs S.C. Seizure-prone EL mice exhibit deficits in pup nursing and retrieval assessed using a novel method of maternal behavior phenotyping. Epilepsy Behav 4 (2003) 57-64
24. Bontekoe C.J., McIlwain K.L., Nieuwenhuizen I.M., Yuva-Paylor L.A., Nellis A., Willemsen R., et al. Knockout mouse model for Fxr2: a model for mental retardation. Hum Mol Genet 11 (2002) 487-498
25. Boonstra A.M., Kooij J.J., Oosterlaan J., Sergeant J.A., Buitelaar J.K., and Van Someren E.J. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 30 (2007) 433-442
26. Bouwmeester H., Gerrits F.M., Roozemond J.G., Snapper J., Ronken E., Kruse C.G., et al. Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats. Int J Neuropsychopharmacol (2006) 1-13
27. Boyle A.E., and Gill K. Sensitivity of AXB/BXA recombinant inbred lines of mice to the locomotor activating effects of cocaine: a quantitative trait loci analysis. Pharmacogenetics 11 (2001) 255-264
28. Branchi I., Bichler Z., Minghetti L., Delabar J.M., Malchiodi-Albedi F., Gonzalez M.C., et al. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. J Neuropathol Exp Neurol 63 (2004) 429-440
29. Branchi I., Capone F., Alleva E., and Costa L.G. Polybrominated diphenyl ethers: neurobehavioral effects following developmental exposure. Neurotoxicology 24 (2003) 449-462
30. Branchi I., Capone F., Vitalone A., Madia F., Santucci D., Alleva E., et al. Early developmental exposure to BDE 99 or Aroclor 1254 affects neurobehavioural profile: interference from the administration route. Neurotoxicology 26 (2005) 183-192
31. Briner W., and Peterson S. Comparison of the behavior of the curly tail and CBA mouse on a neurologic scale. Neurotoxicol Teratol 20 (1998) 503-510
32. Brocco M., Dekeyne A., Veiga S., Girardon S., and Millan M.J. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 71 (2002) 667-680
33. Bruhwyler J., Chleide E., Liegeois J.F., Delarge J., and Mercier M. Effects of specific dopaminergic agonists and antagonists in the open-field test. Pharmacol Biochem Behav 39 (1991) 367-371
34. Brunskill E.W., Ehrman L.A., Williams M.T., Klanke J., Hammer D., Schaefer T.L., et al. Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice. Eur J Neurosci 22 (2005) 1265-1276
35. Burne T.H., McGrath J.J., Eyles D.W., and Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157 (2005) 299-308
36. Cabib S., Puglisi-Allegra S., and Ventura R. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 130 (2002) 103-109
37. Capasso A., and Loizzo A. Clonidine-induced antinociception and locomotor hypoactivity are reduced by dexamethasone in mice. J Pharm Pharmacol 53 (2001) 351-360
38. Carlsson M.L., Martin P., Nilsson M., Sorensen S.M., Carlsson A., Waters S., et al. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice. J Neural Transm 106 (1999) 123-129
39. Castellanos F.X., and Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3 (2002) 617-628
40. Chaperon F., and Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13 (1999) 243-281
41. Chen C., Rainnie D.G., Greene R.W., and Tonegawa S. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science 266 (1994) 291-294
42. Chia L.G., Ni D.R., Cheng F.C., Ho Y.P., and Kuo J.S. Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice. Neurochem Res 24 (1999) 719-722
43. Choi Y.S., Hong S.B., Jeon H.K., Kim E.J., Oh W.J., Joe S.Y., et al. Insertional mutation in the intron 1 of Unc5h3 gene induces ataxic, lean and hyperactive phenotype in mice. Exp Anim 52 (2003) 273-283
44. Chuck T.L., McLaughlin P.J., Arizzi-LaFrance M.N., Salamone J.D., and Correa M. Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia. Life Sci 79 (2006) 154-161
45. Colombo G., Melis S., Brunetti G., Serra S., Vacca G., Carai M.A., et al. GABA(B) receptor inhibition causes locomotor stimulation in mice. Eur J Pharmacol 433 (2001) 101-104
46. Colorado R.A., Shumake J., Conejo N.M., Gonzalez-Pardo H., and Gonzalez-Lima F. Effects of maternal separation, early handling, and standard facility rearing on orienting and impulsive behavior of adolescent rats. Behav Processes 71 (2006) 51-58
47. Colucci-D'Amato L., Perrone-Capano C., and di Porzio U. Chronic activation of ERK and neurodegenerative diseases. Bioessays 25 (2003) 1085-1095
48. Cooper E.M., Hudson A.W., Amos J., Wagstaff J., and Howley P.M. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J Biol Chem 279 (2004) 41208-41217
49. Cowen M.S., Schroff K.C., Gass P., Sprengel R., and Spanagel R. Neurobehavioral effects of alcohol in AMPA receptor subunit (GluR1) deficient mice. Neuropharmacology 45 (2003) 325-333
50. Cox P.R., Fowler V., Xu B., Sweatt J.D., Paylor R., and Zoghbi H.Y. Mice lacking Tropomodulin-2 show enhanced long-term potentiation, hyperactivity, and deficits in learning and memory. Mol Cell Neurosci 23 (2003) 1-12
51. Crabbe J.C., Gallaher E.J., Cross S.J., and Belknap J.K. Genetic determinants of sensitivity to diazepam in inbred mice. Behav Neurosci 112 (1998) 668-677
52. Cressant A., Desmaris N., Verot L., Brejot T., Froissart R., Vanier M.T., et al. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J Neurosci 24 (2004) 10229-10239
53. Cryns K., Shamir A., Van Acker N., Levi I., Daneels G., Goris I., et al. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology 33 (2008) 674-684
54. D'Hooge R., Van Dam D., Franck F., Gieselmann V., and De Deyn P.P. Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy. Brain Res 907 (2001) 35-43
55. Dauge V., Sebret A., Beslot F., Matsui T., and Roques B.P. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology 25 (2001) 690-698
56. Deacon R.M., Brook R.C., Meyer D., Haeckel O., Ashcroft F.M., Miki T., et al. Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2. Physiol Behav 87 (2006) 723-733
57. Dere E., Souza-Silva M.A., Spieler R.E., Lin J.S., Ohtsu H., Haas H.L., et al. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur J Neurosci 20 (2004) 1051-1058
58. Diaz-Granados J.L., Greene P.L., and Amsel A. Selective activity enhancement and persistence in weanling rats after hippocampal X-irradiation in infancy: possible relevance for ADHD. Behav Neural Biol 61 (1994) 251-259
59. Dierssen M., Benavides-Piccione R., Martinez-Cue C., Estivill X., Florez J., Elston G.N., et al. Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment. Cereb Cortex 13 (2003) 758-764
60. Dorval K.M., Wigg K.G., Crosbie J., Tannock R., Kennedy J.L., Ickowicz A., et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav (2006)
61. Drage M.G., and Heinrichs S.C. Phenotyping the untouchables: environmental enhancement of behavioral and physiological activation in seizure-prone El mice. Epilepsy Behav 6 (2005) 35-42
62. Duncan G.E., Moy S.S., Lieberman J.A., and Koller B.H. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 85 (2006) 481-491
63. Duvoisin R.M., Zhang C., Pfankuch T.F., O'Connor H., Gayet-Primo J., Quraishi S., et al. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur J Neurosci 22 (2005) 425-436
64. Dziedzicka-Wasylewska M., Faron-Gorecka A., Kusmider M., Drozdowska E., Rogoz Z., Siwanowicz J., et al. Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 31 (2006) 2424-2432
65. Eells J.B., Lipska B.K., Yeung S.K., Misler J.A., and Nikodem V.M. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 136 (2002) 267-275
66. Elsner J. Tactile-kinesthetic system of rats as an animal model for minimal brain dysfunction. Arch Toxicol 65 (1991) 465-473
67. Engel S.R., Creson T.K., Hao Y., Shen Y., Maeng S., Nekrasova T., et al. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry (2008)
68. Erinoff L., MacPhail R.C., Heller A., and Seiden L.S. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res 164 (1979) 195-205
69. Espinosa F., Marks G., Heintz N., and Joho R.H. Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels. Genes Brain Behav 3 (2004) 90-100
70. Exner C., Hebebrand J., Remschmidt H., Wewetzer C., Ziegler A., Herpertz S., et al. Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol Psychiatry 5 (2000) 476-481
71. Facchinetti F., Ciani E., Dall'Olio R., Virgili M., Contestabile A., and Fonnum F. Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801. Brain Res Dev Brain Res 74 (1993) 219-224
72. Fadda P., Bedogni F., Fresu A., Collu M., Racagni G., and Riva M.A. Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission. Biol Psychiatry (2006)
73. Fadda P., Scherma M., Fresu A., Collu M., and Fratta W. Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice. Synapse 56 (2005) 29-38
74. Ferro M.M., Bellissimo M.I., Anselmo-Franci J.A., Angellucci M.E., Canteras N.S., and Da Cunha C. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. J Neurosci Methods 148 (2005) 78-87
75. Fradley R.L., O'Meara G.F., Newman R.J., Andrieux A., Job D., and Reynolds D.S. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 163 (2005) 257-264
76. Fredriksson A., and Archer T. Functional alteration by NMDA antagonist: effects of l-Dopa, neuroleptics drug and postnatal administration. Amino Acids 23 (2002) 111-132
77. Fredriksson A., and Archer T. Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res 6 (2004) 435-456
78. Fredriksson A., Plaznik A., Sundstrom E., Jonsson G., and Archer T. MPTP-induced hypoactivity in mice: reversal by l-dopa. Pharmacol Toxicol 67 (1990) 295-301
79. Fredriksson A., Schroder N., Eriksson P., Izquierdo I., and Archer T. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res Dev Brain Res 119 (2000) 65-74
80. Fujii H., Ishihama T., Ago Y., Shintani N., Kakuda M., Hashimoto H., et al. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice. Peptides 28 (2007) 1674-1679
81. Fukamauchi F., Wang Y.J., Mataga N., and Kusakabe M. Paradoxical behavioral response to apomorphine in tenascin-gene knockout mouse. Eur J Pharmacol 338 (1997) 7-10
82. Gainetdinov R., Wetsel W., Jones S., Levin E., Jaber M., and Caron M. Role of serotonine in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
83. Gainetdinov R.R., Bohn L.M., Walker J.K., Laporte S.A., Macrae A.D., Caron M.G., et al. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24 (1999) 1029-1036
84. Gassmann M., Shaban H., Vigot R., Sansig G., Haller C., Barbieri S., et al. Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci 24 (2004) 6086-6097
85. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., and Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA 98 (2001) 15312-15317
86. Gerlai R., Pisacane P., and Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res 109 (2000) 219-227
87. Gilbert F., Morissette M., St Hilaire M., Paquet B., Rouillard C., Di Paolo T., et al. Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatry 60 (2006) 538-547
88. Goldberg M.S., Pisani A., Haburcak M., Vortherms T.A., Kitada T., Costa C., et al. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45 (2005) 489-496
89. Haberny K.A., Paule M.G., Scallet A.C., Sistare F.D., Lester D.S., Hanig J.P., et al. Ontogeny of the N-methyl-d-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci 68 (2002) 9-17
90. Harris L.W., Sharp T., Gartlon J., Jones D.N., and Harrison P.J. Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 18 (2003) 1706-1710
91. Hashimoto R., Hashimoto H., Shintani N., Chiba S., Hattori S., Okada T., et al. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 12 (2007) 1026-1032
92. Hendley E.D. WKHA rat with genetic Hyperactivity and Hyperreactivity to stress: a review. Neurosci Biobehav Rev 24 (2000) 41-44
93. Hering E., Epstein R., Elroy S., Iancu D.R., and Zelnik N. Sleep patterns in autistic children. J Autism Dev Disord 29 (1999) 143-147
94. Hewitt K.N., Shah Y.B., Prior M.J., Morris P.G., Hollis C.P., Fone K.C., et al. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder. Psychopharmacology (Berl) 180 (2005) 716-723
95. Highfield D.A., Hu D., and Amsel A. Alleviation of x-irradiation-based deficit in memory-based learning by d-amphetamine: suggestions for attention deficit-hyperactivity disorder. Proc Natl Acad Sci USA 95 (1998) 5785-5788
96. Hirose M., Yokoyama H., and Iinuma K. Theophylline impairs memory/learning in developing mice. Brain Dev 26 (2004) 448-452
97. Hitzemann R., Cipp L., Demarest K., Mahjubi E., and McCaughran Jr. J. Genetics of ethanol-induced locomotor activation: detection of QTLs in a C57BL/6J × DBA/2J F2 intercross. Mamm Genome 9 (1998) 956-962
98. Hnasko T.S., Perez F.A., Scouras A.D., Stoll E.A., Gale S.D., Luquet S., et al. Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc Natl Acad Sci USA 103 (2006) 8858-8863
99. Holmes A., Murphy D.L., and Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161 (2002) 160-167
100. Hommel J.D., Sears R.M., Georgescu D., Simmons D.L., and DiLeone R.J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 9 (2003) 1539-1544
101. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287 (2000) 1056-1060
102. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
103. Iwamoto T., Okumura S., Iwatsubo K., Kawabe J., Ohtsu K., Sakai I., et al. Motor dysfunction in type 5 adenylyl cyclase-null mice. J Biol Chem 278 (2003) 16936-16940
104. Jackson H.C., and Kitchen I. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats. Neuropharmacology 28 (1989) 635-642
105. Jensen F.E., and Wang C. Hypoxia-induced hyperexcitability in vivo and in vitro in the immature hippocampus. Epilepsy Res 26 (1996) 131-140
106. Jiang C., Wan X., He Y., Pan T., Jankovic J., and Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 191 (2005) 154-162
107. Jiang M., Gold M.S., Boulay G., Spicher K., Peyton M., Brabet P., et al. Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci USA 95 (1998) 3269-3274
108. Joho R.H., Street C., Matsushita S., and Knopfel T. Behavioral motor dysfunction in Kv3-type potassium channel-deficient mice. Genes Brain Behav 5 (2006) 472-482
109. Jones M.D., and Hess E.J. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 75 (2003) 209-216
110. Jones M.D., Williams M.E., and Hess E.J. Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant. Pharmacol Biochem Behav 68 (2001) 669-676
111. Jousselin-Hosaja M., Tobin C., Venault P., Joubert C., and Chapouthier G. Effects of adrenal medulla graft on recovery of GABAergic and dopaminergic neuron deficits in mice: behavioural, pharmacological and immunohistochemical study. Behav Brain Res 140 (2003) 185-193
112. Joyce E.M., Stinus L., and Iversen S.D. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology 22 (1983) 1141-1145
113. Justice A., Moran T.H., Deckel A.W., and Robinson R.G. The use of fetal neocortical transplants to treat the hyperactivity resulting from cortical suction lesions in adult rats. Behav Brain Res 33 (1989) 97-104
114. Kaga Y., Shoemaker W.J., Furusho M., Bryant M., Rosenbluth J., Pfeiffer S.E., et al. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci 26 (2006) 12339-12350
115. Kalivas P.W. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J Pharmacol Exp Ther 222 (1982) 37-42
116. Kalueff A.V., Fox M.A., Gallagher P.S., and Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6 (2007) 389-400
117. Kalueff A.V., Jensen C.L., and Murphy D.L. Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Res 1169 (2007) 87-97
118. Kamimura E., Ueno Y., Tanaka S., Sawa H., Yoshioka M., Ueno K.I., et al. New rat model for attention deficit hyperactive disorder (ADHD). Comp Med 51 (2001) 245-251
119. Karasinska J.M., George S.R., Cheng R., and O'Dowd B.F. Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur J Neurosci 22 (2005) 1741-1750
120. Kassed C.A., and Herkenham M. NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety. Behav Brain Res 154 (2004) 577-584
121. Katsuta K., Umemura K., Ueyama N., and Matsuoka N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Eur J Pharmacol 467 (2003) 103-109
122. Kayser V., Elfassi I.E., Aubel B., Melfort M., Julius D., Gingrich J.A., et al. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain 130 (2007) 235-248
123. Khan Z., and Jinnah H.A. Paroxysmal dyskinesias in the lethargic mouse mutant. J Neurosci 22 (2002) 8193-8200
124. Kiang M., Daskalakis Z.J., Christensen B.K., Remington G., and Kapur S. Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects. J Psychiatry Neurosci 28 (2003) 293-299
125. Kim D.S., and Palmiter R.D. Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice. Proc Natl Acad Sci USA 100 (2003) 1346-1351
126. Klein E., Lavie P., Meiraz R., Sadeh A., and Lenox R.H. Increased motor activity and recurrent manic episodes: predictors of rapid relapse in remitted bipolar disorder patients after lithium discontinuation. Biol Psychiatry 31 (1992) 279-284
127. Kobayashi K., Morita S., Sawada H., Mizuguchi T., Yamada K., Nagatsu I., et al. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 270 (1995) 27235-27243
128. Kohlert J.G., and Bloch G.J. A rat model for attention deficit-hyperactivity disorder. Physiol Behav 53 (1993) 1215-1218
129. Kolkman M.J., Streijger F., Linkels M., Bloemen M., Heeren D.J., Hendriks W.J., et al. Mice lacking leukocyte common antigen-related (LAR) protein tyrosine phosphatase domains demonstrate spatial learning impairment in the two-trial water maze and hyperactivity in multiple behavioural tests. Behav Brain Res 154 (2004) 171-182
130. Koob G.F., Stinus L., and Le Moal M. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav Brain Res 3 (1981) 341-359
131. Kostas J., McFarland D.J., and Drew W.G. Lead-inducing hyperactivity. Chronic exposure during the neonatal period in the rat. Pharmacology 14 (1976) 435-442
132. Kostrzewa R.M., Brus R., Kalbfleisch J.H., Perry K.W., and Fuller R.W. Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34 (1994) 161-167
133. Kotlinska J., and Langwinski R. Influence of CGS 8216 on some acute effects of ethanol. Alcohol Alcohol 30 (1995) 601-605
134. Kubos K.L., and Robinson R.G. Asymmetrical effects of cortical island lesions in the rat. Behav Brain Res 11 (1984) 89-93
135. Lamberty Y., and Gower A.J. Cholinergic modulation of spatial learning in mice in a Morris-type water maze. Arch Int Pharmacodyn Ther 309 (1991) 5-19
136. Latysheva N.V., and Rayevsky K.S. Chronic neonatal N-methyl-d-aspartate receptor blockade induces learning deficits and transient hypoactivity in young rats. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 787-794
137. Le Niculescu H., McFarland M.J., Ogden C.A., Balaraman Y., Patel S., Tan J., et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet 147B (2008) 134-166
138. Lebsanft H.B., Kovar K.A., and Schmidt W.J. 3.4-Methylenedioxymethamphetamine and naloxone in rat rotational behaviour and open field. Eur J Pharmacol 516 (2005) 34-39
139. Leriche L., Schwartz J.C., and Sokoloff P. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology 45 (2003) 174-181
140. Li J.X., Han R., Deng Y.P., Chen S.Q., and Liang J.H. Different effects of valproate on methamphetamine- and cocaine-induced behavioral sensitization in mice. Behav Brain Res 161 (2005) 125-132
141. Lin J.S., Sakai K., Vanni-Mercier G., and Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 479 (1989) 225-240
142. Lumley L.A., Robison C.L., Chen W.K., Mark B., and Meyerhoff J.L. Vasopressin into the preoptic area increases grooming behavior in mice. Physiol Behav 73 (2001) 451-455
143. Luttges M.W., and Gerren R.A. Postnatal alpha-methylphenylalanine treatment effects on adult mouse locomotor activity and avoidance learning. Pharmacol Biochem Behav 11 (1979) 493-498
144. Mack J.T., Beljanski V., Soulika A.M., Townsend D.M., Brown C.B., Davis W., et al. Skittish" abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system. Mol Cell Biol 27 (2007) 44-53
145. Magara F., Ricceri F., Wolfer D.P., and Lipp H.-P. The Acallosal mouse strain I/Ln: a putative model of ADHD?. Neurosci Biobehav Rev 24 (2000) 45-50
146. Mandryk M., Fidecka S., Poleszak E., and Malec D. Participation of adenosine system in the ketamine-induced motor activity in mice. Pharmacol Rep 57 (2005) 55-60
147. Marazioti A., Kastellakis A., Antoniou K., Papasava D., and Thermos K. Somatostatin receptors in the ventral pallidum/substantia innominata modulate rat locomotor activity. Psychopharmacology (Berl) 181 (2005) 319-326
148. Masuo Y., Ishido M., Morita M., and Oka S. Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats. Neural Plast 11 (2004) 59-76
149. Mattingly B.A., Rowlett J.K., and Lovell G. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine. Psychopharmacology (Berl) 110 (1993) 320-326
150. McDonald M.P., Wong R., Goldstein G., Weintraub B., Cheng S.Y., and Crawley J.N. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem 5 (1998) 289-301
151. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., and Chesselet M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol 465 (2003) 11-26
152. Metz G.A., and Schwab M.E. Behavioral characterization in a comprehensive mouse test battery reveals motor and sensory impairments in growth-associated protein-43 null mutant mice. Neuroscience 129 (2004) 563-574
153. Mick E., and Faraone S.V. Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17 (2008) 261-270
154. Miller C.L., Burmeister M., and Stevens K.E. Hippocampal auditory gating in the hyperactive mocha mouse. Neurosci Lett 276 (1999) 57-60
155. Mineur Y.S., and Crusio W.E. Behavioral and neuroanatomical characterization of FVB/N inbred mice. Brain Res Bull 57 (2002) 41-47
156. Miranda-Contreras L., Davila-Ovalles R., Benitez-Diaz P., Pena-Contreras Z., and Palacios-Pru E. Effects of prenatal paraquat and mancozeb exposure on amino acid synaptic transmission in developing mouse cerebellar cortex. Brain Res Dev Brain Res 160 (2005) 19-27
157. Mitchell H.A., Ahern T.H., Liles L.C., Javors M.A., and Weinshenker D. The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biol Psychiatry 60 (2006) 1046-1052
158. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100 (2003) 8987-8992
159. Miyakawa T., Yamada M., Duttaroy A., and Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21 (2001) 5239-5250
160. Moran T.H., Kubos K.L., Sanberg P.R., and Robinson R.G. Marked behavioral and biochemical sensitivity to lesion size in the posterior cortex of the rat. Life Sci 35 (1984) 1337-1342
161. Morice E., Denis C., Macario A., Giros B., and Nosten-Bertrand M. Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization. Neuropsychopharmacology 30 (2005) 575-581
162. Moseley A.E., Williams M.T., Schaefer T.L., Bohanan C.S., Neumann J.C., Behbehani M.M., et al. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci 27 (2007) 616-626
163. Nagels G., Engelborghs S., Vloeberghs E., Van Dam D., Pickut B.A., and De Deyn P.P. Actigraphic measurement of agitated behaviour in dementia. Int J Geriatr Psychiatry 21 (2006) 388-393
164. Negishi T., Kawasaki K., Sekiguchi S., Ishii Y., Kyuwa S., Kuroda Y., et al. Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats. Behav Brain Res 159 (2005) 323-331
165. Nilsson M., Markinhuhta K.R., and Carlsson M.L. Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 521-530
166. Nonogaki K., Abdallah L., Goulding E.H., Bonasera S.J., and Tecott L.H. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. Diabetes 52 (2003) 315-320
167. Oades R.D., Taghzouti K., Rivet J.M., Simon H., and Le Moal M. Locomotor activity in relation to dopamine and noradrenaline in the nucleus accumbens, septal and frontal areas: a 6-hydroxydopamine study. Neuropsychobiology 16 (1986) 37-42
168. Otani H., Moriyama K., Yonezawa S., Shoji R., and Tanaka O. Vestibulocochlear defects and effects of deuterium oxide in mutant bustling (BUS) mice. Acta Otolaryngol Suppl 519 (1995) 286-293
169. Ouagazzal A., Nieoullon A., and Amalric M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology (Berl) 111 (1993) 427-434
170. Palomo T., Beninger R.J., Kostrzewa R.M., and Archer T. Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations. Neurotox Res 5 (2003) 1-26
171. Panksepp J., Burgdorf J., Turner C., and Gordon N. Modeling ADHD-type arousal with unilateral frontal cortex damage in rats and beneficial effects of play therapy. Brain Cogn 52 (2003) 97-105
172. Pascoli V., Valjent E., Corbille A.G., Corvol J.C., Tassin J.P., Girault J.A., et al. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors. Mol Pharmacol 68 (2005) 421-429
173. Pau H., Hawker K., Fuchs H., de Angelis M.H., and Steel K.P. Characterization of a new mouse mutant, flouncer, with a balance defect and inner ear malformation. Otol Neurotol 25 (2004) 707-713
174. Peters H.C., Hu H., Pongs O., Storm J.F., and Isbrandt D. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 8 (2005) 51-60
175. Phillips T.J., Huson M., Gwiazdon C., Burkhart-Kasch S., and Shen E.H. Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcohol Clin Exp Res 19 (1995) 269-278
176. Phillips T.J., Huson M.G., and McKinnon C.S. Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice. J Neurosci 18 (1998) 3023-3034
177. Poyurovsky M., Nave R., Epstein R., Tzischinsky O., Schneidman M., Barnes T.R., et al. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia. Eur Neuropsychopharmacol 10 (2000) 171-176
178. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 26 (2006) 9022-9029
179. Pullela R., Raber J., Pfankuch T., Ferriero D.M., Claus C.P., Koh S.E., et al. Traumatic injury to the immature brain results in progressive neuronal loss, hyperactivity and delayed cognitive impairments. Dev Neurosci 28 (2006) 396-409
180. Puumala T., Ruotsalainen S., Jakala P., Koivisto E., Riekkinen Jr. P., and Sirvio J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem 66 (1996) 198-211
181. Ralph-Williams R.J., Paulus M.P., Zhuang X., Hen R., and Geyer M.A. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 53 (2003) 352-359
182. Realmuto G.M., Garfinkel B.D., Tuchman M., Tsai M.Y., Chang P.N., Fisch R.O., et al. Psychiatric diagnosis and behavioral characteristics of phenylketonuric children. J Nerv Ment Dis 174 (1986) 536-540
183. Rhodes J.S., and Garland Jr. T. Differential sensitivity to acute administration of Ritalin, apormorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior. Psychopharmacology (Berl) 167 (2003) 242-250
184. Robbins T.W., Granon S., Muir J.L., Durantou F., Harrison A., and Everitt B.J. Neural systems underlying arousal and attention-implications for drug abuse. Ann NY Acad Sci 846 (1998) 222-237
185. Roeltgen D.P., and Schneider J.S. Chronic low-dose MPTP in nonhuman primates: a possible model for attention deficit disorder. J Child Neurol 6 Suppl (1991) S82-S89
186. Rousselet E., Joubert C., Callebert J., Parain K., Tremblay L., Orieux G., et al. Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis 14 (2003) 218-228
187. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997) 991-1001
188. Sadile A.G. What can genetic models tell us about behavioral plasticity?. Rev Neurosci 4 (1993) 287-303
189. Cerbone A., and Sadile A.G. Behavioral habituation to spatial novelty: interference and noninterference studies. Neurosci Biobehav Rev 18 (1994) 497-518
190. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., and Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 58 (1992) 103-112
191. Sakai N., Sakurai E., Onodera K., Sakurai E., Asada H., Miura Y., et al. Long-term depletion of brain histamine induced by alpha-fluoromethylhistidine increases feeding-associated locomotor activity in mice with a modulation of brain amino acid levels. Behav Brain Res 72 (1995) 83-88
192. Salahpour A., Medvedev I.O., Beaulieu J.M., Gainetdinov R.R., and Caron M.G. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 61 (2007) 65-69
193. Sanudo-Pena M.C., Romero J., Seale G.E., Fernandez-Ruiz J.J., and Walker J.M. Activational role of cannabinoids on movement. Eur J Pharmacol 391 (2000) 269-274
194. Scheres A., Milham M.P., Knutson B., and Castellanos F.X. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry 61 (2007) 720-724
195. Schiefer J., Sprunken A., Puls C., Luesse H.G., Milkereit A., Milkereit E., et al. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease. Brain Res 1019 (2004) 246-254
196. Schilling G., Jinnah H.A., Gonzales V., Coonfield M.L., Kim Y., Wood J.D., et al. Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA. Neurobiol Dis 8 (2001) 405-418
197. Seaman R.L., Belt M.L., Doyle J.M., and Mathur S.P. Hyperactivity caused by a nitric oxide synthase inhibitor is countered by ultra-wideband pulses. Bioelectromagnetics 20 (1999) 431-439
198. Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 24 (2000) 7-12
199. Sgado P., Alberi L., Gherbassi D., Galasso S.L., Ramakers G.M., Alavian K.N., et al. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc Natl Acad Sci USA 103 (2006) 15242-15247
200. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35 (2002) 243-254
201. Shaywitz B.A., Yager R.D., and Klopper J.H. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191 (1976) 305-308
202. Shin D.M., Korada S., Raballo R., Shashikant C.S., Simeone A., Taylor J.R., et al. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J Neurosci 24 (2004) 2247-2258
203. Shiozaki S., Ichikawa S., Nakamura J., Kitamura S., Yamada K., and Kuwana Y. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology (Berl) 147 (1999) 90-95
204. Siesser W.B., Cheng S.Y., and McDonald M.P. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse. Psychopharmacology (Berl) 181 (2005) 653-663
205. Siuciak J.A., McCarthy S.A., Chapin D.S., Martin A.N., Harms J.F., and Schmidt C.J. Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background. Neuropharmacology 54 (2008) 417-427
206. Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., et al. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25 (2005) 914-922
207. Sollars P.J., Ryan A., Ogilvie M.D., and Pickard G.E. Altered circadian rhythmicity in the Wocko mouse, a hyperactive transgenic mutant. Neuroreport 7 (1996) 1245-1248
208. Son G.H., Chung S., Geum D., Kang S.S., Choi W.S., Kim K., et al. Hyperactivity and alteration of the midbrain dopaminergic system in maternally stressed male mice offspring. Biochem Biophys Res Commun 352 (2007) 823-829
209. Speiser Z., Korczyn A.D., Teplitzky I., and Gitter S. Hyperactivity in rats following postnatal anoxia. Behav Brain Res 7 (1983) 379-382
210. Speiser Z., Levy R., and Cohen S. Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. J Neural Transm Suppl 52 (1998) 287-300
211. Stefani M.R., and Moghaddam B. Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 57 (2005) 433-436
212. Stewart L.S., Bercovici E., Shukla R., Serbanescu I., Persad V., Mistry N., et al. Daily rhythms of seizure activity and behavior in a model of atypical absence epilepsy. Epilepsy Behav 9 (2006) 564-572
213. Stone E.A., Lin Y., Ahsan M.R., and Quartermain D. Evidence of roles of central alpha1-adrenoceptors and epinephrine in orexin A-induced hyperactivity in mice. Neurosci Lett 381 (2005) 325-328
214. Strekalova T., Spanagel R., Dolgov O., and Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 16 (2005) 171-180
215. Sukhanov I.M., Zakharova E.S., Danysz W., and Bespalov A.Y. Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats. Behav Pharmacol 15 (2004) 263-271
216. Sundstrom E., Fredriksson A., and Archer T. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res 528 (1990) 181-188
217. Surendran S., Campbell G.A., Tyring S.K., Matalon K., McDonald J.D., and Matalon R. High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU. Neurochem Res 28 (2003) 1891-1894
218. Tanaka K., Shintani N., Hashimoto H., Kawagishi N., Ago Y., Matsuda T., et al. Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 26 (2006) 5091-5097
219. Tani K., Iyo M., Matsumoto H., Kawai M., Suzuki K., Iwata Y., et al. The effects of dentate granule cell destruction on behavioural activity and Fos protein expression induced by systemic methamphetamine in rats. Br J Pharmacol 134 (2001) 1411-1418
220. Tenk C.M., Kavaliers M., and Ossenkopp K.P. Dose response effects of lithium chloride on conditioned place aversions and locomotor activity in rats. Eur J Pharmacol 515 (2005) 117-127
221. Tenk C.M., Kavaliers M., and Ossenkopp K.P. The effects of acute corticosterone on lithium chloride-induced conditioned place aversion and locomotor activity in rats. Life Sci 79 (2006) 1069-1080
222. Theis M., Jauch R., Zhuo L., Speidel D., Wallraff A., Doring B., et al. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J Neurosci 23 (2003) 766-776
223. Torres G., Hallas B.H., Vernace V.A., Jones C., Gross K.W., and Horowitz J.M. A neurobehavioral screening of the ckr mouse mutant: implications for an animal model of schizophrenia. Brain Res Bull 62 (2004) 315-326
224. Tran T.T., Chowanadisai W., Lonnerdal B., Le L., Parker M., Chicz-Demet A., et al. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 23 (2002) 645-651
225. Umemori H., Ogura H., Tozawa N., Mikoshiba K., Nishizumi H., and Yamamoto T. Impairment of N-methyl-d-aspartate receptor-controlled motor activity in LYN-deficient mice. Neuroscience 118 (2003) 709-713
226. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367 (1971) 95-122
227. Unis A.S., Petracca F., and Diaz J. Somatic and behavioral ontogeny in three rat strains: preliminary observations of dopamine-mediated behaviors and brain D-1 receptors. Prog Neuropsychopharmacol Biol Psychiatry 15 (1991) 129-138
228. Vacher C.M., Gassmann M., Desrayaud S., Challet E., Bradaia A., Hoyer D., et al. Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. J Neurochem 97 (2006) 979-991
229. Valenti P., Cozzio A., Nishida N., Wolfer D.P., Sakaguchi S., and Lipp H.P. Similar target, different effects: late-onset ataxia and spatial learning in prion protein-deficient mouse lines. Neurogenetics 3 (2001) 173-184
230. Varty G.B., Powell S.B., Lehmann-Masten V., Buell M.R., and Geyer M.A. Isolation rearing of mice induces deficits in prepulse inhibition of the startle response. Behav Brain Res 169 (2006) 162-167
231. Vasilev V., Veskov R., Janac B., Rakic L., and Stojiljkovic M. Age-related differences in MK-801- and amphetamine-induced locomotor and stereotypic activities of rats. Neurobiol Aging 24 (2003) 715-723
232. Velley L., Mormede P., and Kempf E. Neurochemical lesion of the nucleus locus coeruleus increases neophobia in a specific exploration task but does not modify endocrine response to moderate stress. Pharmacol Biochem Behav 29 (1988) 1-7
233. Ventura R., Pascucci T., Catania M.V., Musumeci S.A., and Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 15 (2004) 433-442
234. Vetulani J., Antkiewicz-Michaluk L., Nalepa I., and Sansone M. A possible physiological role for cerebral tetrahydroisoquinolines. Neurotox Res 5 (2003) 147-155
235. Viberg H., Fredriksson A., and Eriksson P. Investigations of strain and/or gender differences in developmental neurotoxic effects of polybrominated diphenyl ethers in mice. Toxicol Sci 81 (2004) 344-353
236. Viggiano D., Ruocco L.A., Arcieri S., and Sadile A.G. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Neural Plast 11 (2004) 133-149
237. Viollet C., Vaillend C., Videau C., Bluet-Pajot M.T., Ungerer A., L'Heritier A., et al. Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. Eur J Neurosci 12 (2000) 3761-3770
238. Vitali R., and Clarke S. Improved rotorod performance and hyperactivity in mice deficient in a protein repair methyltransferase. Behav Brain Res 153 (2004) 129-141
239. Volkow N.D., and Swanson J.M. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?. Am J Psychiatry 165 (2008) 553-555
240. Weese G.D., Phillips J.M., and Brown V.J. Attentional orienting is impaired by unilateral lesions of the thalamic reticular nucleus in the rat. J Neurosci 19 (1999) 10135-10139
241. Weinshenker D., Miller N.S., Blizinsky K., Laughlin M.L., and Palmiter R.D. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci USA 99 (2002) 13873-13877
242. Weiss J., Takizawa B., McGee A., Stewart W.B., Zhang H., Ment L., et al. Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity. Exp Neurol 189 (2004) 141-149
243. Whishaw I.Q., O'Connor W.T., and Dunnett S.B. Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation. Behav Brain Res 17 (1985) 103-115
244. Wilcoxon J.S., Nadolski G.J., Samarut J., Chassande O., and Redei E.E. Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor alpha. Behav Brain Res 177 (2007) 109-116
245. Wilson M.C. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 24 (2000) 51-58
246. Winter B., Juckel G., Viktorov I., Katchanov J., Gietz A., Sohr R., et al. Anxious and hyperactive phenotype following brief ischemic episodes in mice. Biol Psychiatry 57 (2005) 1166-1175
247. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79 (1994) 729-742
248. Yamaguchi H., Aiba A., Nakamura K., Nakao K., Sakagami H., Goto K., et al. Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells 1 (1996) 253-268
249. Yee B.K., Keist R., von Boehmer L., Studer R., Benke D., Hagenbuch N., et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 102 (2005) 17154-17159
250. Zeyda T., Diehl N., Paylor R., Brennan M.B., and Hochgeschwender U. Impairment in motor learning of somatostatin null mutant mice. Brain Res 906 (2001) 107-114
251. Zhao S., Edwards J., Carroll J., Wiedholz L., Millstein R.A., Jaing C., et al. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 140 (2006) 321-334
252. Zhdanova I.V., Wurtman R.J., and Wagstaff J. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab 12 (1999) 57-67
253. Zhou K., Asherson P., Sham P., Franke B., Anney R.J., Buitelaar J., et al. Linkage to chromosome 1p36 for attention-deficit/hyperactivity disorder traits in school and home settings. Biol Psychiatry (2008)
254. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 98 (2001) 1982-1987
255. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96 (1999) 5780-5785
256. Zueger M., Urani A., Chourbaji S., Zacher C., Roche M., Harkin A., et al. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett 374 (2005) 142-146
257. Zuo D.Y., Zhang Y.H., Cao Y., Wu C.F., Tanaka M., and Wu Y.L. Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior. Life Sci 78 (2006) 2172-2178